SCHEMBL25754554

SCHEMBL25754554

COc1ccc(NC(=O)c2cccc(-n3cncn3)c2)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
GAA P10253 3/20 0.46
KDM4E B2RXH2 3/20 0.46
POLB P06746 2/20 0.46
HTT P42858 2/20 0.46
LMNA P02545 6/20 0.45
HPGD P15428 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
ALDH1A1 P00352 4/20 0.44
APOBEC3G Q9HC16 2/20 0.44
EPHX2 P34913 1/20 0.44
ALOX12 P18054 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
MAPK8 P45983 1/20 0.43
MAPK10 P53779 1/20 0.43
CPT1A P50416 1/20 0.43
CPT1B Q92523 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23846618 0.87 EPHX2 (0.61) MAPTGAAKDM4EHTTLMNA
SCHEMBL23846449 0.85 ABL1 (0.52) MAPTGAAKDM4EPOLBHTT
SCHEMBL25755369 0.82 MAPT (0.56) MAPTGAAKDM4EPOLBHTT
SCHEMBL23846597 0.81 EPHX2 (0.43) MAPTKDM4EPOLBALDH1A1EPHX2
SCHEMBL23846562 0.81 EGFR (0.51) MAPTGAAKDM4ELMNAHPGD
SCHEMBL26014709 0.81 MAPK1 (0.65) MAPTGAAKDM4EPOLBHTT
SCHEMBL25758307 0.80 ABL1 (0.53) MAPTGAAKDM4EPOLBHTT
SCHEMBL25754531 0.80 ALPL (0.47) GAALMNAHPGDSMN1; SMN2MEN1
SCHEMBL23846589 0.79 NPC1 (0.56) MAPTGAAPOLBLMNAHPGD
SCHEMBL23846519 0.78 HCRTR2 (0.61) MAPTGAAKDM4EPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 MAPT 89/4885GAA 1667/4885KDM4E 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.